Safety of psychotropic drugs in pregnancy

Affiliations

¹ Section of Women's Mental Health, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
² Section of Women's Mental Health, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK louise.howard@kcl.ac.uk.

Editorial

Hind Khalifeh et al. BMJ. 2015.

. 2015 May 13:350:h2260.

doi: 10.1136/bmj.h2260.

¹ Section of Women's Mental Health, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
² Section of Women's Mental Health, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK louise.howard@kcl.ac.uk.

No abstract available

Comment on

Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.
Furu K, Kieler H, Haglund B, Engeland A, Selmer R, Stephansson O, Valdimarsdottir UA, Zoega H, Artama M, Gissler M, Malm H, Nørgaard M. Furu K, et al. BMJ. 2015 Apr 17;350:h1798. doi: 10.1136/bmj.h1798. BMJ. 2015. PMID: 25888213 Free PMC article.
Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study.
Vigod SN, Gomes T, Wilton AS, Taylor VH, Ray JG. Vigod SN, et al. BMJ. 2015 May 13;350:h2298. doi: 10.1136/bmj.h2298. BMJ. 2015. PMID: 25972273 Free PMC article.